Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients
Breast cancer (BC) is one of the most frequent cancer types in women worldwide. About 7% is diagnosed in young women (YBC) less than 40 years old. In Mexico, however, YBC reaches 15% suggesting a higher genetic susceptibility. There have been some reports of germline variants in YBC across the world...
Gespeichert in:
Veröffentlicht in: | Cancers 2022-03, Vol.14 (7), p.1647 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 7 |
container_start_page | 1647 |
container_title | Cancers |
container_volume | 14 |
creator | Gómez-Flores-Ramos, Liliana Barraza-Arellano, Angélica Leticia Mohar, Alejandro Trujillo-Martínez, Miguel Grimaldo, Lizbeth Ortiz-Lopez, Rocío Treviño, Víctor |
description | Breast cancer (BC) is one of the most frequent cancer types in women worldwide. About 7% is diagnosed in young women (YBC) less than 40 years old. In Mexico, however, YBC reaches 15% suggesting a higher genetic susceptibility. There have been some reports of germline variants in YBC across the world. However, there is only one report from a Mexican population, which is not restricted by age and limited to a panel of 143 genes resulting in 15% of patients carrying putatively pathogenic variants. Nevertheless, expanding the analysis to whole exome involves using more complex tools to determine which genes and variants could be pathogenic. We used germline whole exome sequencing combined with the PeCanPie tool to analyze exome variants in 115 YBC patients. Our results showed that we were able to identify 49 high likely pathogenic variants involving 40 genes on 34% of patients. We noted many genes already reported in BC and YBC worldwide, such as
,
,
,
,
, and
, but also others not commonly reported in YBC in Latin America, such as
,
,
,
, and
. We show further supporting and controversial evidence for some of these genes. We conclude that exome sequencing combined with robust annotation tools and further analysis, can identify more genes and more patients affected by germline mutations in cancer. |
doi_str_mv | 10.3390/cancers14071647 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8997148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2649593281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-692073826ef5b68ceacd7e0495e60e413d93928d26f816acac02a6002b824bae3</originalsourceid><addsrcrecordid>eNpdkUtLAzEUhYMoVqprdzLgxs3YvJpJNoIWraKiCxVchUx6p0ZmMjWZEf33pr7QZpPA_e7JORyEdgk-ZEzhkTXeQoiE44IIXqyhLYoLmguh-Pqf9wDtxPiM02GMFKLYRAM25lhwirfQ5RRCUzsP2YMJzvguZs5nk0_lbAoeYlaFtske297Ps5MAJnY_42t4c8lDdms6B2lzG21Upo6w830P0f3Z6d3kPL-6mV5Mjq9yyynpcqGSNSapgGpcCmnB2FkBmKsxCAycsJliisoZFZUkwlhjMTUCY1pKyksDbIiOvnQXfdnAzKa_g6n1IrjGhHfdGqf_T7x70vP2VUulCsJlEjj4FgjtSw-x042LFuraeGj7qKlIZhSjkiR0fwV9bvvgU7wlJZVMWZbU6IuyoY0xQPVrhmC97EqvdJU29v5m-OV_mmEfBu-QNw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2648982071</pqid></control><display><type>article</type><title>Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Gómez-Flores-Ramos, Liliana ; Barraza-Arellano, Angélica Leticia ; Mohar, Alejandro ; Trujillo-Martínez, Miguel ; Grimaldo, Lizbeth ; Ortiz-Lopez, Rocío ; Treviño, Víctor</creator><creatorcontrib>Gómez-Flores-Ramos, Liliana ; Barraza-Arellano, Angélica Leticia ; Mohar, Alejandro ; Trujillo-Martínez, Miguel ; Grimaldo, Lizbeth ; Ortiz-Lopez, Rocío ; Treviño, Víctor</creatorcontrib><description>Breast cancer (BC) is one of the most frequent cancer types in women worldwide. About 7% is diagnosed in young women (YBC) less than 40 years old. In Mexico, however, YBC reaches 15% suggesting a higher genetic susceptibility. There have been some reports of germline variants in YBC across the world. However, there is only one report from a Mexican population, which is not restricted by age and limited to a panel of 143 genes resulting in 15% of patients carrying putatively pathogenic variants. Nevertheless, expanding the analysis to whole exome involves using more complex tools to determine which genes and variants could be pathogenic. We used germline whole exome sequencing combined with the PeCanPie tool to analyze exome variants in 115 YBC patients. Our results showed that we were able to identify 49 high likely pathogenic variants involving 40 genes on 34% of patients. We noted many genes already reported in BC and YBC worldwide, such as
,
,
,
,
, and
, but also others not commonly reported in YBC in Latin America, such as
,
,
,
, and
. We show further supporting and controversial evidence for some of these genes. We conclude that exome sequencing combined with robust annotation tools and further analysis, can identify more genes and more patients affected by germline mutations in cancer.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers14071647</identifier><identifier>PMID: 35406420</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>BRCA1 protein ; BRCA2 protein ; Breast cancer ; Genomics ; Life span ; Mutation ; Patients ; Population studies ; Womens health</subject><ispartof>Cancers, 2022-03, Vol.14 (7), p.1647</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-692073826ef5b68ceacd7e0495e60e413d93928d26f816acac02a6002b824bae3</citedby><cites>FETCH-LOGICAL-c421t-692073826ef5b68ceacd7e0495e60e413d93928d26f816acac02a6002b824bae3</cites><orcidid>0000-0002-6523-6618 ; 0000-0002-7783-026X ; 0000-0002-7472-9844 ; 0000-0002-4617-639X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997148/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997148/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35406420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gómez-Flores-Ramos, Liliana</creatorcontrib><creatorcontrib>Barraza-Arellano, Angélica Leticia</creatorcontrib><creatorcontrib>Mohar, Alejandro</creatorcontrib><creatorcontrib>Trujillo-Martínez, Miguel</creatorcontrib><creatorcontrib>Grimaldo, Lizbeth</creatorcontrib><creatorcontrib>Ortiz-Lopez, Rocío</creatorcontrib><creatorcontrib>Treviño, Víctor</creatorcontrib><title>Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>Breast cancer (BC) is one of the most frequent cancer types in women worldwide. About 7% is diagnosed in young women (YBC) less than 40 years old. In Mexico, however, YBC reaches 15% suggesting a higher genetic susceptibility. There have been some reports of germline variants in YBC across the world. However, there is only one report from a Mexican population, which is not restricted by age and limited to a panel of 143 genes resulting in 15% of patients carrying putatively pathogenic variants. Nevertheless, expanding the analysis to whole exome involves using more complex tools to determine which genes and variants could be pathogenic. We used germline whole exome sequencing combined with the PeCanPie tool to analyze exome variants in 115 YBC patients. Our results showed that we were able to identify 49 high likely pathogenic variants involving 40 genes on 34% of patients. We noted many genes already reported in BC and YBC worldwide, such as
,
,
,
,
, and
, but also others not commonly reported in YBC in Latin America, such as
,
,
,
, and
. We show further supporting and controversial evidence for some of these genes. We conclude that exome sequencing combined with robust annotation tools and further analysis, can identify more genes and more patients affected by germline mutations in cancer.</description><subject>BRCA1 protein</subject><subject>BRCA2 protein</subject><subject>Breast cancer</subject><subject>Genomics</subject><subject>Life span</subject><subject>Mutation</subject><subject>Patients</subject><subject>Population studies</subject><subject>Womens health</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkUtLAzEUhYMoVqprdzLgxs3YvJpJNoIWraKiCxVchUx6p0ZmMjWZEf33pr7QZpPA_e7JORyEdgk-ZEzhkTXeQoiE44IIXqyhLYoLmguh-Pqf9wDtxPiM02GMFKLYRAM25lhwirfQ5RRCUzsP2YMJzvguZs5nk0_lbAoeYlaFtske297Ps5MAJnY_42t4c8lDdms6B2lzG21Upo6w830P0f3Z6d3kPL-6mV5Mjq9yyynpcqGSNSapgGpcCmnB2FkBmKsxCAycsJliisoZFZUkwlhjMTUCY1pKyksDbIiOvnQXfdnAzKa_g6n1IrjGhHfdGqf_T7x70vP2VUulCsJlEjj4FgjtSw-x042LFuraeGj7qKlIZhSjkiR0fwV9bvvgU7wlJZVMWZbU6IuyoY0xQPVrhmC97EqvdJU29v5m-OV_mmEfBu-QNw</recordid><startdate>20220324</startdate><enddate>20220324</enddate><creator>Gómez-Flores-Ramos, Liliana</creator><creator>Barraza-Arellano, Angélica Leticia</creator><creator>Mohar, Alejandro</creator><creator>Trujillo-Martínez, Miguel</creator><creator>Grimaldo, Lizbeth</creator><creator>Ortiz-Lopez, Rocío</creator><creator>Treviño, Víctor</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6523-6618</orcidid><orcidid>https://orcid.org/0000-0002-7783-026X</orcidid><orcidid>https://orcid.org/0000-0002-7472-9844</orcidid><orcidid>https://orcid.org/0000-0002-4617-639X</orcidid></search><sort><creationdate>20220324</creationdate><title>Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients</title><author>Gómez-Flores-Ramos, Liliana ; Barraza-Arellano, Angélica Leticia ; Mohar, Alejandro ; Trujillo-Martínez, Miguel ; Grimaldo, Lizbeth ; Ortiz-Lopez, Rocío ; Treviño, Víctor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-692073826ef5b68ceacd7e0495e60e413d93928d26f816acac02a6002b824bae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>BRCA1 protein</topic><topic>BRCA2 protein</topic><topic>Breast cancer</topic><topic>Genomics</topic><topic>Life span</topic><topic>Mutation</topic><topic>Patients</topic><topic>Population studies</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gómez-Flores-Ramos, Liliana</creatorcontrib><creatorcontrib>Barraza-Arellano, Angélica Leticia</creatorcontrib><creatorcontrib>Mohar, Alejandro</creatorcontrib><creatorcontrib>Trujillo-Martínez, Miguel</creatorcontrib><creatorcontrib>Grimaldo, Lizbeth</creatorcontrib><creatorcontrib>Ortiz-Lopez, Rocío</creatorcontrib><creatorcontrib>Treviño, Víctor</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gómez-Flores-Ramos, Liliana</au><au>Barraza-Arellano, Angélica Leticia</au><au>Mohar, Alejandro</au><au>Trujillo-Martínez, Miguel</au><au>Grimaldo, Lizbeth</au><au>Ortiz-Lopez, Rocío</au><au>Treviño, Víctor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2022-03-24</date><risdate>2022</risdate><volume>14</volume><issue>7</issue><spage>1647</spage><pages>1647-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Breast cancer (BC) is one of the most frequent cancer types in women worldwide. About 7% is diagnosed in young women (YBC) less than 40 years old. In Mexico, however, YBC reaches 15% suggesting a higher genetic susceptibility. There have been some reports of germline variants in YBC across the world. However, there is only one report from a Mexican population, which is not restricted by age and limited to a panel of 143 genes resulting in 15% of patients carrying putatively pathogenic variants. Nevertheless, expanding the analysis to whole exome involves using more complex tools to determine which genes and variants could be pathogenic. We used germline whole exome sequencing combined with the PeCanPie tool to analyze exome variants in 115 YBC patients. Our results showed that we were able to identify 49 high likely pathogenic variants involving 40 genes on 34% of patients. We noted many genes already reported in BC and YBC worldwide, such as
,
,
,
,
, and
, but also others not commonly reported in YBC in Latin America, such as
,
,
,
, and
. We show further supporting and controversial evidence for some of these genes. We conclude that exome sequencing combined with robust annotation tools and further analysis, can identify more genes and more patients affected by germline mutations in cancer.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35406420</pmid><doi>10.3390/cancers14071647</doi><orcidid>https://orcid.org/0000-0002-6523-6618</orcidid><orcidid>https://orcid.org/0000-0002-7783-026X</orcidid><orcidid>https://orcid.org/0000-0002-7472-9844</orcidid><orcidid>https://orcid.org/0000-0002-4617-639X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6694 |
ispartof | Cancers, 2022-03, Vol.14 (7), p.1647 |
issn | 2072-6694 2072-6694 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8997148 |
source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
subjects | BRCA1 protein BRCA2 protein Breast cancer Genomics Life span Mutation Patients Population studies Womens health |
title | Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A18%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Germline%20Variants%20in%20Cancer%20Genes%20from%20Young%20Breast%20Cancer%20Mexican%20Patients&rft.jtitle=Cancers&rft.au=G%C3%B3mez-Flores-Ramos,%20Liliana&rft.date=2022-03-24&rft.volume=14&rft.issue=7&rft.spage=1647&rft.pages=1647-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers14071647&rft_dat=%3Cproquest_pubme%3E2649593281%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2648982071&rft_id=info:pmid/35406420&rfr_iscdi=true |